On Thursday, January 2, 2025, Cathie Wood-led Ark Invest made a sole notable trade in 10X Genomics Inc (TXG).
This move comes shortly after Ark’s significant Tesla divestment at the end of 2024, as the investment firm continues to adjust its portfolio strategy.
The TXG Trade: Ark Invest made a substantial purchase of 10X Genomics Inc (TXG) shares on Thursday, January 2, 2025. The flagship fund, ARKK, acquired 21,735 shares, while ARKG added 3,667 shares to its holdings. The transactions, totaling 25,402 shares, were valued at approximately $370,000 based on TXG’s closing price of $14.19 on the same day.
This acquisition reflects Ark’s ongoing interest in the genomics sector, a key area of focus for the firm’s long-term investment strategy.
10X Genomics has been a recurring investment target for Ark, aligning with their emphasis on disruptive innovation in healthcare.
Ark’s decision to increase its stake in TXG is consistent with its broader investment thesis. The firm has consistently highlighted the potential of genomics to revolutionize healthcare, making TXG a fitting addition to its carefully curated portfolio. The recent trades suggest a continued confidence in the sector’s potential to deliver significant returns over time.
There were no other trades made on Thursday.
What does it take to achieve financial independence and retire early? Fire Fast by Dzambhala helps you understand and plan it out.